Author: admin

Maintaining a healthy lifestyle-specifically, a diet rich in fibre but light on red/processed meat, regular exercise, not smoking, and sticking to a normal weight-is linked to a significantly lower risk of diverticulitis, finds a large long term study, published online in the journal Gut.

What’s more, these 5 components seem to offset the effects of inherited genes, the findings indicate.

Diverticulitis occurs when ‘pouches’ develop along the gut and become inflamed or infected in the wall of the large intestine (colon), explain the researchers. It’s a common cause of hospital admissions and a major reason for emergency colon surgery, they add.

Genetic and environmental factors, including lifestyle, contribute to the development of the condition, but it’s not clear exactly how these factors interact or the extent to which lifestyle might offset the genetic risk, they say.

To shed more light on this, the researchers derived an overall healthy lifestyle score (0-5) for diverticulitis from survey responses for 179,564 participants drawn from three prospective studies: the Nurses’ Health Study (NHS), NHSII, and the Health Professionals Follow-Up Study.

The score was based on 5 elements that have independently been associated with heightened risks of developing diverticulitis: smoking; weight (BMI); physical activity; fibre intake; and red/processed meat intake. 

The association between this score and incident diverticulitis was confirmed among 30,750 participants in the Southern Community Cohort Study (SCCS). 

Genetic risk was assessed using a polygenic risk score (PRS) in 36,077 people with available genotype information. 

During a monitoring period of 20 years, 10,299 new cases of diverticulitis were recorded. The 5 lifestyle factors were each significantly associated with the development of the condition. 

For example, compared with participants with a BMI below 25, those who were overweight were 32% more likely to develop diverticulitis, while those who were obese were 44% more likely to do so. 

Participants who had formerly or who were still smoking were, respectively, 17% and 13% more likely to be diagnosed with diverticulitis than those who had never smoked. And higher levels of physical activity were associated with a 16% reduced risk compared with lower levels. 

While higher fibre intake was associated with a 14% lower risk, higher red meat intake was associated with a 9% increased risk. 

And every 1-point increase in healthy lifestyle score was associated with a 12% lower risk of diverticulitis. Participants with a score of 5 were 50% less likely to be diagnosed with the condition than those with a score of 0.

The findings were consistently observed across all three studies and in different racial groups.

The association between healthy lifestyle score and incident diverticulitis was confirmed among 30,750 participants in the Southern Community Cohort Study (SCCS). 

Some 2183 new cases of diverticulitis were reported during an average monitoring period of nearly 12 years in this group. Those with a healthy lifestyle score of 3–5 had a substantially lower risk (31%) than those with a score of 0. 

Genetic risk was assessed using a polygenic (cumulative) risk score (PRS) in 36,077 people with available genotype information in the NHS, NHSII, and HPFS groups.

There were no notable differences in lifestyle factors across PRS categories, but PRS was significantly associated with incident diverticulitis. For each unit increase in PRS, the risk increased by 58%, and was particularly evident among those under the age of 60. 

And a healthy lifestyle seemed to offset genetic susceptibility to the condition. For example, those in the lowest PRS category and with a healthy lifestyle score of 4-5 were 37% less likely to develop diverticulitis compared to those with a score of 0.

Similarly, those with a medium PRS were 48% less likely to do so, while those in the highest PRS category were 50% less likely to do so. Further analysis showed that adopting a healthy lifestyle might prevent 23–42% of diverticulitis cases across PRS categories.

And when the effect of PRS and a healthy lifestyle score were combined, those in the highest PRS category with a healthy lifestyle score of 0 or 1 were 5 times more likely to develop diverticulitis than those in the lowest PRS category with a score of 4 or 5. 

The findings were further validated in the Mass General Brigham Biobank (MGBB).

This is an observational study, and as such, can’t establish cause. And the researchers acknowledge that ascertainment of diverticulitis was based on different approaches across the different studies.

Nevertheless, they conclude: “Our data provide consistent evidence from multiple data sets indicating that adherence to a healthy lifestyle is linked to a reduced risk of developing diverticulitis, irrespective of one’s genetic predisposition.”

A real-world, multicenter study of 67 evaluable patients treated with fecal microbiota, live-jslm (RBL), demonstrated a 77.6% treatment success rate at 8 weeks for preventing recurrent Clostridioides difficile infection (rCDI), with 87% maintaining remission at six months. These findings support RBL’s safety and efficacy beyond controlled clinical trials in an elderly, comorbid population frequently exposed to multiple rCDI risk factors.¹

RBL, FDA-approved in November 2022 as the first microbiota-based product for rCDI prevention in adults, is administered rectally after standard-of-care antibiotics. The study population had a median age of 74 years and a median Charlson comorbidity score of 4, with over half having three or more prior CDI recurrences. Risk factors were prevalent, including advanced age (72%), gastric acid suppressant use (55%), immunocompromise (24%), and recent non-CDI antibiotic exposure (21%).¹

All patients received prior antibiotics, most commonly fidaxomicin (58%), before RBL administration. Adverse events were minimal, limited to minor leakage in 5 patients. Age ≥65 was significantly associated with higher recurrence risk. Among patients experiencing recurrence within 8 weeks, median time to relapse was 28 days. Of 30 patients with 6-month follow-up data, 26 (87%) sustained treatment response.¹

These data provide important evidence for clinicians managing complex rCDI cases, highlighting RBL as a valuable and well-tolerated intervention to reduce recurrence risk in routine practice.¹

In relation to RBL, in a recent interview with Paul Feuerstadt, MD, FACG, AGAF, he emphasized that beyond effectively reducing recurrent Clostridioides difficile infections, the treatment plays a crucial role in improving patients’ overall quality of life. Feuerstadt described how recurrent CDI often leads to significant anxiety, fear, and social isolation, likening the emotional burden to post-traumatic stress. He noted that RBL not only targets the infection but also helps restore patients’ mental, physical, and social well-being, allowing them to regain confidence and normalcy in their daily lives.²

Reference

1.Seo S, Hengel R, Krishnan S, et al. Real-World Experience with Fecal Microbiota Treatment (live-jslm) for the Prevention of Recurrent Clostridioides difficile Infection. Abstract 85 E. MAD-ID Meeting. May 28–31, 2025. Orlando, FL.

2.Improved Symptoms and Health-Related Quality of Life in Adults with Recurrent Clostridioides Difficile Infection after Fecal Microbiota, Live-jslm (RBL) Administration by Colonoscopy. Abstract presented at DDW 2025, May 3-6, 2025. Accessed July 1, 2025.